A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

NCT ID: NCT03539744

Last Updated: 2025-06-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

265 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-10-22

Study Completion Date

2027-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A study designed tocompare progression-free survival (PFS) in participants with t(11;14)-positive MM treated with venetoclax in combination with dexamethasone versus pomalidomide in combination with dexamethasone.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Myeloma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm 1 VenDex

Venetoclax administered orally once daily (QD) plus dexamethasone administered orally once every week (Q1W) for each 28-day cycle.

Group Type EXPERIMENTAL

Dexamethasone

Intervention Type DRUG

oral, locally available form

Venetoclax

Intervention Type DRUG

tablet; oral

Arm 2 PomDex

Pomalidomide administered orally once daily (QD) on Days 1 - 21 for each 28-day cycle plus dexamethasone administered orally once every week (Q1W) for each 28-day cycle.

Group Type ACTIVE_COMPARATOR

Pomalidomide

Intervention Type DRUG

capsule, oral

Dexamethasone

Intervention Type DRUG

oral, locally available form

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pomalidomide

capsule, oral

Intervention Type DRUG

Dexamethasone

oral, locally available form

Intervention Type DRUG

Venetoclax

tablet; oral

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Pomalyst ABT-199 GDC-0199

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Documented diagnosis of multiple myeloma (MM) based on standard International Myeloma Working Group (IMWG) criteria.
* Measurable disease at screening as defined per protocol.
* Has received at least 2 prior lines of therapy as described in the protocol.
* Has had documented disease progression on or within 60 days after completion of the last therapy.
* Has received at least 2 consecutive cycles of lenalidomide and be relapsed/refractory to lenalidomide, as defined per protocol.
* Has received at least 2 consecutive cycles of a proteasome inhibitor (PI).
* Has t(11;14)-positive status determined by an analytically validated fluorescent in situ hybridization (FISH) assay per centralized laboratory testing.
* An Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 2.
* Laboratory values (liver, kidney and hematology laboratory values) that meet criteria as described per protocol.

Exclusion Criteria

* History of treatment with venetoclax or another B-Cell Lymphoma (BCL)-2 inhibitor or pomalidomide.
* History of other active malignancies, including myelodysplastic syndromes (MDS), within the past 3 years (exceptions described in the protocol).
* Evidence of ongoing graft-versus-host disease (GvHD) if prior stem cell transplant (SCT).
* Prior treatment with any of the following: allogeneic or syngeneic SCT within 16 weeks prior to randomization; or autologous SCT within 12 weeks prior to randomization.
* Known central nervous system involvement of MM.
* Concurrent conditions as listed in the protocol.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Roche-Genentech

INDUSTRY

Sponsor Role collaborator

AbbVie

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

ABBVIE INC.

Role: STUDY_DIRECTOR

AbbVie

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Duplicate_University of Arizona Cancer Center - North Campus /ID# 218407

Tucson, Arizona, United States

Site Status

VA Central California Health Care System /ID# 200047

Fresno, California, United States

Site Status

University of California, Los Angeles /ID# 171524

Los Angeles, California, United States

Site Status

Rocky Mountain Regional VA Medical Center/Eastern Colorado Health Care System /ID# 222904

Aurora, Colorado, United States

Site Status

Mayo Clinic /ID# 200075

Jacksonville, Florida, United States

Site Status

Cleveland Clinic Florida /ID# 208884

Weston, Florida, United States

Site Status

Duplicate_Norton Cancer Institute /ID# 200834

Louisville, Kentucky, United States

Site Status

University of Maryland, Baltimore /ID# 217422

Baltimore, Maryland, United States

Site Status

Boston Medical Center /ID# 223606

Boston, Massachusetts, United States

Site Status

Barbara Ann Karmanos Cancer In /ID# 201377

Detroit, Michigan, United States

Site Status

Duplicate_Henry Ford Hospital /ID# 171531

Detroit, Michigan, United States

Site Status

Mayo Clinic - Rochester /ID# 201091

Rochester, Minnesota, United States

Site Status

Columbia University Medical Center /ID# 200715

New York, New York, United States

Site Status

Fairview Hospital - Moll Pavilion /ID# 208919

Cleveland, Ohio, United States

Site Status

Cleveland Clinic Main Campus /ID# 202247

Cleveland, Ohio, United States

Site Status

UPMC Hillman Cancer Ctr /ID# 200063

Pittsburgh, Pennsylvania, United States

Site Status

MD Anderson Cancer Center at Texas Medical Center /ID# 200060

Houston, Texas, United States

Site Status

Huntsman Cancer Institute /ID# 218406

Salt Lake City, Utah, United States

Site Status

VA Puget Sound Health Care System /ID# 222708

Seattle, Washington, United States

Site Status

Liverpool Hospital /ID# 202431

Liverpool, New South Wales, Australia

Site Status

Sydney Adventist Hospital /ID# 222874

Wahroonga, New South Wales, Australia

Site Status

Wollongong Hospital /ID# 205545

Wollongong, New South Wales, Australia

Site Status

ICON Cancer Care - Townsville /ID# 206565

Hyde Park, Queensland, Australia

Site Status

Icon Cancer Centre /ID# 205663

South Brisbane, Queensland, Australia

Site Status

The Queen Elizabeth Hospital /ID# 202432

Woodville South, South Australia, Australia

Site Status

Perth Blood Institute Ltd /ID# 206649

Nedlands, Western Australia, Australia

Site Status

Arthur J. E. Child Comprehensive Cancer Centre /ID# 218846

Calgary, Alberta, Canada

Site Status

BC Cancer - Vancouver /ID# 222804

Vancouver, British Columbia, Canada

Site Status

Queen Elizabeth II Health Sciences Centre - Victoria General /ID# 218883

Halifax, Nova Scotia, Canada

Site Status

CISSS-CA (Centre Integre de sante et de services sociaux de Chaudiere-Appalache) /ID# 218887

Lévis, Quebec, Canada

Site Status

Beijing Chaoyang Hospital,Capital Medical University /ID# 216014

Beijing, Beijing Municipality, China

Site Status

Peking University Third Hospital /ID# 216371

Beijing, Beijing Municipality, China

Site Status

Peking Union Medical College Hospital (East) - Dongdan Campus /ID# 216040

Beijing, Beijing Municipality, China

Site Status

Sun Yat-Sen University Cancer Center /ID# 223828

Guangzhou, Guangdong, China

Site Status

Guangdong Provincial People's Hospital /ID# 215860

Guangzhou, Guangdong, China

Site Status

Henan Cancer Hospital /ID# 215987

Zhengzhou, Henan, China

Site Status

Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 215850

Wuhan, Hubei, China

Site Status

Nanjing Drum Tower Hospital /ID# 223143

Nanjing, Jiangsu, China

Site Status

The First Affiliated Hospital of Soochow University /ID# 216094

Suzhou, Jiangsu, China

Site Status

The First Affiliated Hospital of Nanchang University /ID# 216954

Nanchang, Jiangxi, China

Site Status

The First Hospital of China Medical University /ID# 215996

Shenyang, Liaoning, China

Site Status

Shengjing Hospital of China Medical University /ID# 223435

Shenyang, Liaoning, China

Site Status

Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 216643

Shanghai, Shanghai Municipality, China

Site Status

Shanghai Tongji Hospital /ID# 218865

Shanghai, Shanghai Municipality, China

Site Status

West China Hospital, Sichuan University /ID# 216647

Chengdu, Sichuan, China

Site Status

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc /ID# 216041

Tianjin, Tianjin Municipality, China

Site Status

Tianjin Medical University Cancer Institute & Hospital /ID# 223550

Tianjin, Tianjin Municipality, China

Site Status

The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 215989

Hangzhou, Zhejiang, China

Site Status

The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 218691

Hangzhou, Zhejiang, China

Site Status

The First Affiliated Hospital of Wenzhou Medical University /ID# 218953

Wenzhou, Zhejiang, China

Site Status

Beijing Chaoyang Hospital, Capital Medical University(West campus) /ID# 234033

Beijing, , China

Site Status

Fakultní Nemocnice Brno - Jihlavská /ID# 204512

Brno, Brno-mesto, Czechia

Site Status

Fakultní nemocnice Hradec Králové - Sokolská /ID# 221291

Hradec Králové, Hradec Kralove, Czechia

Site Status

Fakultni Nemocnice Ostrava /ID# 204515

Ostrava, Ostrava-mesto, Czechia

Site Status

Fakultni nemocnice Olomouc /ID# 221290

Olomouc, , Czechia

Site Status

Vseobecna fakultni nemocnice v Praze /ID# 221166

Prague, , Czechia

Site Status

Duplicate_Herlev Hospital /ID# 223221

Herlev, Capital Region, Denmark

Site Status

Aalborg University Hospital /ID# 223220

Aalborg, North Denmark, Denmark

Site Status

Odense University Hospital /ID# 223217

Odense, Region Syddanmark, Denmark

Site Status

Sygehus Lillebalt, Vejle /ID# 223216

Vejle, Region Syddanmark, Denmark

Site Status

Duplicate_Roskilde Hospital /ID# 223366

Roskilde, , Denmark

Site Status

Duplicate_CHU Grenoble - Hopital Michallon /ID# 223182

La Tronche, Isere, France

Site Status

CHU Reims - Hôpital Robert Debre /ID# 233907

Reims, Marne, France

Site Status

CHRU Nancy - Hopitaux de Brabois /ID# 201076

Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France

Site Status

CHRU Lille - Hopital Claude Huriez /ID# 202213

Lille, Nord, France

Site Status

Hopitaux Universitaires Henri Mondor - Hopital Henri Mondor /ID# 202211

Créteil, Paris, France

Site Status

CHU de Nantes, Hotel Dieu -HME /ID# 200099

Nantes, Pays de la Loire Region, France

Site Status

HCL - Hopital Lyon Sud /ID# 200097

Pierre-Bénite, Rhone, France

Site Status

Centre Henri Becquerel /ID# 223186

Rouen, Seine-Maritime, France

Site Status

CH Henri Duffaut /ID# 234154

Avignon, Vaucluse, France

Site Status

Hopital Pitie Salpetriere /ID# 214173

Paris, Île-de-France Region, France

Site Status

Robert-Bosch-Krankenhaus /ID# 223947

Stuttgart, Baden-Wurttemberg, Germany

Site Status

Universitaetsklinikum Tuebingen /ID# 238646

Tübingen, Baden-Wurttemberg, Germany

Site Status

Universitaetsklinikum Wuerzburg /ID# 200055

Würzburg, Bavaria, Germany

Site Status

Klinikum Chemnitz gGmbH /ID# 233797

Chemnitz, Saxony, Germany

Site Status

Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 201830

Kiel, Schleswig-Holstein, Germany

Site Status

Universitaetsklinikum Jena /ID# 201254

Jena, Thuringia, Germany

Site Status

Charite Universitaetsklinikum Berlin - Campus Benjamin Franklin /ID# 200051

Berlin, , Germany

Site Status

Universitaetsklinikum Hamburg-Eppendorf /ID# 215495

Hamburg, , Germany

Site Status

Asklepios Klinik Altona /ID# 222506

Hamburg, , Germany

Site Status

Alexandra General Hospital /ID# 202386

Athens, Attica, Greece

Site Status

University General Hospital of Heraklion PA.G.N.I /ID# 222879

Heraklion, Crete, Greece

Site Status

General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 213982

Athens, , Greece

Site Status

University Gen Hosp of Patra /ID# 201691

Pátrai, , Greece

Site Status

Theageneio Anticancer Hospital /ID# 213983

Thessaloniki, , Greece

Site Status

General Hospital of Thessaloniki George Papanikolaou /ID# 201692

Thessaloniki, , Greece

Site Status

Rambam Health Care Campus /ID# 169678

Haifa, H_efa, Israel

Site Status

Bnai Zion Medical Center /ID# 169466

Haifa, H_efa, Israel

Site Status

The Lady Davis Carmel Medical Center /ID# 222969

Haifa, H_efa, Israel

Site Status

Hadassah /ID# 169474

Jerusalem, Jerusalem, Israel

Site Status

Duplicate_Assuta Ashdod Medical Center /ID# 222968

Ashdod, Southern District, Israel

Site Status

Soroka University Medical Center /ID# 218768

Beersheba, Southern District, Israel

Site Status

The Chaim Sheba Medical Center /ID# 169778

Ramat Gan, Tel Aviv, Israel

Site Status

Tel Aviv Sourasky Medical Center /ID# 169437

Tel Aviv, Tel Aviv, Israel

Site Status

Rabin Medical Center /ID# 244611

Petah Tikva, , Israel

Site Status

Duplicate_IRCCS AOU di Bologna - Policlinico Sant'Orsola-Malpighi /ID# 170952

Bologna, Emilia-Romagna, Italy

Site Status

A.O.U. CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO - Ospedale Molinette /ID# 170962

Turin, Piedmont, Italy

Site Status

Irccs-Crob /Id# 170955

Rionero in Vulture, Potenza, Italy

Site Status

Azienda Ospedaliero Universitaria delle Marche /ID# 170950

Ancona, , Italy

Site Status

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico /ID# 212498

Milan, , Italy

Site Status

Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello /ID# 222988

Palermo, , Italy

Site Status

Azienda Ospedaliera Santa Maria Terni /ID# 170948

Terni, , Italy

Site Status

Nagoya City University Hospital /ID# 170880

Nagoya, Aichi-ken, Japan

Site Status

The Jikei University Kashiwa Hospital /ID# 223031

Kashiwa-shi, Chiba, Japan

Site Status

Kyushu University Hospital /ID# 171117

Fukuoka, Fukuoka, Japan

Site Status

Ogaki Municipal Hospital /ID# 171043

Ogaki-shi, Gifu, Japan

Site Status

Gunma University Hospital /ID# 170966

Maebashi, Gunma, Japan

Site Status

Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital /ID# 171255

Hiroshima, Hiroshima, Japan

Site Status

Kobe City Medical Center General Hospital /ID# 170992

Kobe, Hyōgo, Japan

Site Status

Duplicate_National Hospital Organization Mito Medical Center /ID# 171187

Higashi Ibaraki-gun, Ibaraki, Japan

Site Status

Hitachi General Hospital /ID# 200843

Hitachi-shi, Ibaraki, Japan

Site Status

Iwate Medical University Hospital /ID# 222849

Shiwa-gun, Iwate, Japan

Site Status

Tohoku University Hospital /ID# 201935

Sendai, Miyagi, Japan

Site Status

Okayama Medical Center /ID# 200119

Okayama, Okayama-ken, Japan

Site Status

Japanese Red Cross Osaka Hospital /ID# 171493

Osaka, Osaka, Japan

Site Status

The University of Osaka Hospital /ID# 201966

Suita-shi, Osaka, Japan

Site Status

Tokushima University Hospital /ID# 202571

Tokushima, Tokushima, Japan

Site Status

The Jikei University Hospital /ID# 239014

Minato-ku, Tokyo, Japan

Site Status

Japanese Red Cross Medical Center /ID# 171256

Shibuya-ku, Tokyo, Japan

Site Status

Yamagata University Hospital /ID# 238329

Yamagata, Yamagata, Japan

Site Status

Moscow State budget healthcare /ID# 169685

Moscow, Moscow, Russia

Site Status

Research Institute of Fundamental and Clinical Immunology /ID# 223594

Novosibirsk, Novosibirsk Oblast, Russia

Site Status

LLC Novaya Klinika /ID# 169689

Pyatigorsk, Stavropol Kray, Russia

Site Status

City Clinical Hospital #52 /ID# 206289

Moscow, , Russia

Site Status

Leningrad Regional Clinical Hospital /ID# 202776

Saint Petersburg, , Russia

Site Status

Almazov National Medical Research Centre /ID# 169681

Saint Petersburg, , Russia

Site Status

Tula Regional Clinical Hospital /ID# 223226

Tula, , Russia

Site Status

National University Hospital /ID# 203988

Singapore, , Singapore

Site Status

Singapore General Hospital /ID# 202131

Singapore, , Singapore

Site Status

Tan Tock Seng Hospital /ID# 204374

Singapore, , Singapore

Site Status

Duplicate_Gachon University Gil Medical Center /ID# 202827

Incheon, Gyeonggido, South Korea

Site Status

Seoul National University Hospital /ID# 202711

Seoul, Seoul Teugbyeolsi, South Korea

Site Status

Samsung Medical Center /ID# 202710

Seoul, Seoul Teugbyeolsi, South Korea

Site Status

The Catholic University of Korea, Seoul St. Marys Hospital /ID# 234045

Seoul, Seoul Teugbyeolsi, South Korea

Site Status

Ulsan University Hospital /ID# 222716

Ulsan, Ulsan Gwang Yeogsi, South Korea

Site Status

Yonsei University Health System Severance Hospital /ID# 202709

Seoul, , South Korea

Site Status

Hospital Universitari Son Espases /ID# 222889

Palma de Mallorca, Balearic Islands, Spain

Site Status

Hospital Costa del Sol /ID# 234083

Marbella, Malaga, Spain

Site Status

Complejo Hospitalario Universitario Ourense /ID# 222876

Ourense, Ourense, Spain

Site Status

Hospital Universitario Canarias /ID# 238452

San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain

Site Status

Hospital Universitario Vall d'Hebron /ID# 218106

Barcelona, , Spain

Site Status

Instituto Catalan de Oncologia (ICO) Girona /ID# 171311

Girona, , Spain

Site Status

Hospital de Leon /ID# 233878

León, , Spain

Site Status

Hospital Universitario Fundacion Jimenez Diaz /ID# 171304

Madrid, , Spain

Site Status

Disc_Hospital Universitario 12 de Octubre /ID# 171288

Madrid, , Spain

Site Status

Hospital Universitario La Paz /ID# 218107

Madrid, , Spain

Site Status

Hospital Universitario de Salamanca /ID# 171294

Salamanca, , Spain

Site Status

Hospital Universitario Virgen del Rocio /ID# 171286

Seville, , Spain

Site Status

Hospital General Universitario de Toledo /ID# 222887

Toledo, , Spain

Site Status

Hospital Universitario y Politecnico La Fe /ID# 234019

Valencia, , Spain

Site Status

Sunderby sjukhus /ID# 201314

Luleå, Norrbotten County, Sweden

Site Status

Sodra Alvsborgs sjukhus /ID# 213061

Borås, Västra Götaland County, Sweden

Site Status

Duplicate_Universitetssjukhuset Linköping /ID# 200789

Linkoping, Västra Götaland County, Sweden

Site Status

Uddevalla sjukhus /ID# 201315

Uddevalla, Västra Götaland County, Sweden

Site Status

Cukurova Universitesi Tip Fakultesi /ID# 201955

Saricam Adana, Adana, Turkey (Türkiye)

Site Status

Izmir Ekonomi Universitesi Ozel Medicalpoint Hastanesi /ID# 201954

Cordaleo, İzmir, Turkey (Türkiye)

Site Status

Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi /ID# 201956

Ankara, , Turkey (Türkiye)

Site Status

Gazi University Medical Faculty /ID# 222698

Ankara, , Turkey (Türkiye)

Site Status

Ankara Univ Medical Faculty /ID# 201881

Ankara, , Turkey (Türkiye)

Site Status

Istanbul University Istanbul Medical Faculty /ID# 201953

Istanbul, , Turkey (Türkiye)

Site Status

Bagcilar Medipol Mega Universite Hastanesi /ID# 222914

Istanbul, , Turkey (Türkiye)

Site Status

Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi /ID# 201952

Istanbul, , Turkey (Türkiye)

Site Status

Ege University Medical Faculty /ID# 222697

Izmir, , Turkey (Türkiye)

Site Status

Communal Nonprofit Enterprise Cherkasy Regional Oncology Dispensary /ID# 223943

Cherkasy, Cherkasy Oblast, Ukraine

Site Status

Communal non-profit enterprise Regional Center of Oncology /ID# 223945

Kharkiv, Kharkivs’ka Oblast’, Ukraine

Site Status

MNI Khmelnytskyi Regional Hospital of Khmelnytskyi Regional Council /ID# 223942

Khmelnytskyi, , Ukraine

Site Status

National Cancer Institute /ID# 223944

Kyiv, , Ukraine

Site Status

SI Institute of Blood Pathology and Transfusion Medicine of NAMS of Ukraine /ID# 223941

Lviv, , Ukraine

Site Status

Addenbrooke's Hospital /ID# 223097

Cambridge, Cambridgeshire, United Kingdom

Site Status

Hammersmith Hospital /ID# 171446

London, England, United Kingdom

Site Status

University College London Hospital /ID# 171428

London, Greater London, United Kingdom

Site Status

Norfolk and Norwich University Hospitals NHS Foundation Trust /ID# 218213

Norwich, Norfolk, United Kingdom

Site Status

Duplicate_Nottingham University Hospitals NHS Trust /ID# 223292

Nottingham, Nottinghamshire, United Kingdom

Site Status

Duplicate_NHS Greater Glasgow and Clyde /ID# 202199

Glasgow, Scotland, United Kingdom

Site Status

Duplicate_University Hospitals North Midlands - Royal Stoke University Hospital /ID# 218355

Stoke-on-Trent, Staffordshire, United Kingdom

Site Status

Duplicate_Duplicate_Lewisham and Greenwich NHS Trust /ID# 171445

London, , United Kingdom

Site Status

Manchester University NHS Foundation Trust /ID# 171440

Manchester, , United Kingdom

Site Status

Portsmouth Hospitals University NHS Trust /ID# 171444

Portsmouth, , United Kingdom

Site Status

Royal Berkshire NHS Foundation Trust /ID# 217835

Reading, , United Kingdom

Site Status

Duplicate_Sheffield Teaching Hospitals NHS Foundation Trust - Royal Hallamshire /ID# 171447

Sheffield, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Canada China Czechia Denmark France Germany Greece Israel Italy Japan Russia Singapore South Korea Spain Sweden Turkey (Türkiye) Ukraine United Kingdom

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-506112-40

Identifier Type: OTHER

Identifier Source: secondary_id

M13-494

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.